;PMID: 11389059
;source_file_711.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..36] = [t:0..36]
;1)sentence:[e:41..117] = [t:41..117]
;2)section:[e:121..213] = [t:121..213]
;3)section:[e:217..321] = [t:217..321]
;4)sentence:[e:325..373] = [t:325..373]
;5)sentence:[e:374..539] = [t:374..539]
;6)sentence:[e:540..717] = [t:540..717]
;7)sentence:[e:719..794] = [t:719..794]
;8)sentence:[e:796..1150] = [t:796..1150]
;9)sentence:[e:1151..1313] = [t:1151..1313]
;10)sentence:[e:1314..1432] = [t:1314..1432]
;11)sentence:[e:1434..1602] = [t:1434..1602]
;12)sentence:[e:1603..1744] = [t:1603..1744]
;13)sentence:[e:1745..1867] = [t:1745..1867]
;14)sentence:[e:1868..1983] = [t:1868..1983]
;15)section:[e:1987..2032] = [t:1987..2032]

;section 0 Span:0..36
;Cancer Res  2001 Jun 1;61(11):4350-6
(SEC
  (FRAG (NNP:[0..6] Cancer) (NNP:[7..10] Res) (CD:[12..16] 2001)
        (IN:[17..20] Jun) (CD:[21..26] 1;61-LRB-) (CD:[26..28] 11)
        (-RRB-:[28..29] -RRB-) (CD:[29..34] :4350) (::[34..35] -)
        (CD:[35..36] 6)))

;sentence 1 Span:41..117
;p53 and K-ras mutations in lung cancers from former and never-smoking women.
;[41..44]:gene-rna:"p53"
;[49..54]:gene-rna:"K-ras"
;[68..80]:malignancy:"lung cancers"
(SENT
  (NP-HLN
    (NP-SBJ
      (NP (NN:[41..44] p53)
        (NML-3 (-NONE-:[44..44] *P*)))
      (CC:[45..48] and)
      (NP (NN:[49..54] K-ras)
        (NML-3 (NNS:[55..64] mutations))))
    (PP-LOC (IN:[65..67] in)
      (NP
        (NP (NN:[68..72] lung) (NNS:[73..80] cancers))
        (PP (IN:[81..85] from)
          (NP
            (NP
              (ADJP (JJ:[86..92] former)
                (ADJP-1 (-NONE-:[92..92] *P*)))
              (NML-2 (-NONE-:[92..92] *P*)))
            (CC:[93..96] and)
            (NP
              (ADJP (RB:[97..102] never) (HYPH:[102..103] -)
                (ADJP-1 (VBG:[103..110] smoking)))
              (NML-2 (NNS:[111..116] women)))))))
    (.:[116..117] .)))

;section 2 Span:121..213
;Vahakangas KH, Bennett WP, Castren K, Welsh JA, Khan MA, Blomeke B, Alavanja
;MC,  Harris CC.
(SEC
  (FRAG (NNP:[121..131] Vahakangas) (NNP:[132..134] KH) (,:[134..135] ,)
        (NNP:[136..143] Bennett) (NNP:[144..146] WP) (,:[146..147] ,)
        (NNP:[148..155] Castren) (NNP:[156..157] K) (,:[157..158] ,)
        (NNP:[159..164] Welsh) (NNP:[165..167] JA) (,:[167..168] ,)
        (NNP:[169..173] Khan) (NNP:[174..176] MA) (,:[176..177] ,)
        (NNP:[178..185] Blomeke) (NNP:[186..187] B) (,:[187..188] ,)
        (NNP:[189..197] Alavanja) (NNP:[198..200] MC) (,:[200..201] ,)
        (NNP:[203..209] Harris) (NNP:[210..213] CC.)))

;section 3 Span:217..321
;Department of Pharmacology and Toxicology, University of Oulu, P. O. Box
;5000,  FIN-90014 Oulu, Finland.
(SEC
  (FRAG (NNP:[217..227] Department) (IN:[228..230] of)
        (NNP:[231..243] Pharmacology) (CC:[244..247] and)
        (NNP:[248..258] Toxicology) (,:[258..259] ,) (NNP:[260..270] University)
        (IN:[271..273] of) (NNP:[274..278] Oulu) (,:[278..279] ,)
        (NNP:[280..282] P.) (NNP:[283..285] O.) (NNP:[286..289] Box)
        (CD:[290..294] 5000) (,:[294..295] ,) (NNP:[297..300] FIN)
        (::[300..301] -) (CD:[301..306] 90014) (NNP:[307..311] Oulu)
        (,:[311..312] ,) (NNP:[313..320] Finland) (.:[320..321] .)))

;sentence 4 Span:325..373
;Somatic p53 mutations are common in lung cancer.
;[333..336]:gene-rna:"p53"
;[361..372]:malignancy:"lung cancer"
(SENT
  (S
    (NP-SBJ (JJ:[325..332] Somatic) (NN:[333..336] p53)
            (NNS:[337..346] mutations))
    (VP (VBP:[347..350] are)
      (ADJP-PRD (JJ:[351..357] common))
      (PP (IN:[358..360] in)
        (NP (NN:[361..365] lung) (NN:[366..372] cancer))))
    (.:[372..373] .)))

;sentence 5 Span:374..539
;Active cigarette smoking is  positively correlated with the total frequency
;of p53 mutations and G:C to T:A  transversions on the nontranscribed (DNA
;coding) strand.
;[453..456]:gene-rna:"p53"
;[471..474]:variation-state-original:"G:C"
;[478..481]:variation-state-altered:"T:A"
;[483..496]:variation-type:"transversions"
(SENT
  (S
    (NP-SBJ-1 (JJ:[374..380] Active) (NN:[381..390] cigarette)
              (NN:[391..398] smoking))
    (VP (VBZ:[399..401] is)
      (VP
        (ADVP (RB:[403..413] positively))
        (VBN:[414..424] correlated)
        (NP-1 (-NONE-:[424..424] *))
        (PP-CLR (IN:[425..429] with)
          (NP
            (NP (DT:[430..433] the) (JJ:[434..439] total)
                (NN:[440..449] frequency))
            (PP (IN:[450..452] of)
              (NP
                (NP (NN:[453..456] p53) (NNS:[457..466] mutations))
                (CC:[467..470] and)
                (NP
                  (NML
                    (NML (NN:[471..472] G) (SYM:[472..473] :) (NN:[473..474] C))
                    (PP (TO:[475..477] to)
                      (NP (NN:[478..479] T) (SYM:[479..480] :) (NN:[480..481] A))))
                  (NNS:[483..496] transversions))))
            (PP (IN:[497..499] on)
              (NP (DT:[500..503] the) (JJ:[504..518] nontranscribed)
                (PRN (-LRB-:[519..520] -LRB-)
                  (NP (NN:[520..523] DNA) (NN:[524..530] coding))
                  (-RRB-:[530..531] -RRB-))
                (NN:[532..538] strand)))))))
    (.:[538..539] .)))

;sentence 6 Span:540..717
;Mutational hotspots  within the p53 gene, e.g., codon 157, have been
;identified for tobacco-related  lung cancer, whereas these same mutations are
;found rarely in other cancers.
;[572..575]:gene-rna:"p53"
;[588..597]:variation-location:"codon 157"
;[641..652]:malignancy:"lung cancer"
;[673..682]:variation-event:"mutations"
(SENT
  (S
    (NP-SBJ-2
      (NP (JJ:[540..550] Mutational) (NNS:[551..559] hotspots))
      (PP (IN:[561..567] within)
        (NP (DT:[568..571] the) (NN:[572..575] p53) (NN:[576..580] gene)))
      (,:[580..581] ,)
      (PP (FW:[582..586] e.g.) (,:[586..587] ,)
        (NP (NN:[588..593] codon) (CD:[594..597] 157))))
    (,:[597..598] ,)
    (VP (VBP:[599..603] have)
      (VP (VBN:[604..608] been)
        (VP (VBN:[609..619] identified)
          (NP-2 (-NONE-:[619..619] *))
          (PP (IN:[620..623] for)
            (NP
              (ADJP (NN:[624..631] tobacco) (HYPH:[631..632] -)
                    (VBN:[632..639] related))
               (NN:[641..645] lung) (NN:[646..652] cancer)))
          (,:[652..653] ,)
          (SBAR-ADV (IN:[654..661] whereas)
            (S
              (NP-SBJ-1 (DT:[662..667] these) (JJ:[668..672] same)
                        (NNS:[673..682] mutations))
              (VP (VBP:[683..686] are)
                (VP (VBN:[687..692] found)
                  (NP-1 (-NONE-:[692..692] *))
                  (ADVP-TMP (RB:[693..699] rarely))
                  (PP (IN:[700..702] in)
                    (NP (JJ:[703..708] other) (NNS:[709..716] cancers))))))))))
    (.:[716..717] .)))

;sentence 7 Span:719..794
;Such data implicate specific p53 mutations as molecular markers of smoking.
;[748..751]:gene-rna:"p53"
(SENT
  (S
    (NP-SBJ (JJ:[719..723] Such) (NNS:[724..728] data))
    (VP (VBP:[729..738] implicate)
      (NP
        (NP (JJ:[739..747] specific) (NN:[748..751] p53)
            (NNS:[752..761] mutations))
        (PP (IN:[762..764] as)
          (NP
            (NP (JJ:[765..774] molecular) (NNS:[775..782] markers))
            (PP (IN:[783..785] of)
              (NP (NN:[786..793] smoking)))))))
    (.:[793..794] .)))

;sentence 8 Span:796..1150
;Because limited data exist concerning the p53 mutation frequency and spectra
;in  ex-smokers and nonsmokers, we have analyzed p53 and K-ras mutations in
;126 lung  cancers from a population-based case-control study of nonsmoking (n
;= 117) or  ex-smoking (n = 9) women from Missouri with quantitative
;assessments of exposure  to environmental tobacco smoke.
;[838..841]:gene-rna:"p53"
;[921..924]:gene-rna:"p53"
;[929..934]:gene-rna:"K-ras"
;[952..965]:malignancy:"lung  cancers"
(SENT
  (S
    (SBAR-ADV (IN:[796..803] Because)
      (S
        (NP-SBJ (JJ:[804..811] limited) (NNS:[812..816] data))
        (VP (VBP:[817..822] exist)
          (S-ADV
            (NP-SBJ (-NONE-:[822..822] *))
            (VP (VBG:[823..833] concerning)
              (NP
                (NP (DT:[834..837] the)
                  (NML
                    (NML
                      (NML-3 (NN:[838..841] p53) (NN:[842..850] mutation))
                      (NN:[851..860] frequency))
                    (CC:[861..864] and)
                    (NML
                      (NML-3 (-NONE-:[864..864] *P*))
                      (NNS:[865..872] spectra))))
                (PP (IN:[873..875] in)
                  (NP
                    (NP (AFX:[877..879] ex) (HYPH:[879..880] -)
                        (NNS:[880..887] smokers))
                    (CC:[888..891] and)
                    (NP (NNS:[892..902] nonsmokers))))))))))
    (,:[902..903] ,)
    (NP-SBJ (PRP:[904..906] we))
    (VP (VBP:[907..911] have)
      (VP (VBN:[912..920] analyzed)
        (NP
          (NP
            (NP (NN:[921..924] p53)
              (NML-2 (-NONE-:[924..924] *P*)))
            (CC:[925..928] and)
            (NP (NN:[929..934] K-ras)
              (NML-2 (NNS:[935..944] mutations))))
          (PP (IN:[945..947] in)
            (NP
              (NP (CD:[948..951] 126)
                 (NN:[952..956] lung) (NNS:[958..965] cancers))
              (PP (IN:[966..970] from)
                (NP
                  (NP (DT:[971..972] a)
                    (ADJP (NN:[973..983] population) (HYPH:[983..984] -)
                          (VBN:[984..989] based))
                    (NML (NN:[990..994] case) (HYPH:[994..995] -)
                         (NN:[995..1002] control))
                    (NN:[1003..1008] study))
                  (PP (IN:[1009..1011] of)
                    (NP
                      (NP
                        (NP (JJ:[1012..1022] nonsmoking)
                          (PRN (-LRB-:[1023..1024] -LRB-)
                            (S
                              (NP-SBJ (NN:[1024..1025] n))
                              (VP (SYM:[1026..1027] =)
                                (NP (CD:[1028..1031] 117))))
                            (-RRB-:[1031..1032] -RRB-))
                          (NML-1 (-NONE-:[1032..1032] *P*)))
                        (CC:[1033..1035] or)
                        (NP
                          (ADJP (AFX:[1037..1039] ex) (HYPH:[1039..1040] -)
                                (VBG:[1040..1047] smoking))
                          (PRN (-LRB-:[1048..1049] -LRB-)
                            (S
                              (NP-SBJ (NN:[1049..1050] n))
                              (VP (SYM:[1051..1052] =)
                                (NP (CD:[1053..1054] 9))))
                            (-RRB-:[1054..1055] -RRB-))
                          (NML-1 (NNS:[1056..1061] women))))
                      (PP (IN:[1062..1066] from)
                        (NP (NNP:[1067..1075] Missouri)))
                      (PP (IN:[1076..1080] with)
                        (NP
                          (NP (JJ:[1081..1093] quantitative)
                              (NNS:[1094..1105] assessments))
                          (PP (IN:[1106..1108] of)
                            (NP
                              (NP (NN:[1109..1117] exposure))
                              (PP (TO:[1119..1121] to)
                                (NP (JJ:[1122..1135] environmental)
                                    (NN:[1136..1143] tobacco)
                                    (NN:[1144..1149] smoke))))))))))))))))
    (.:[1149..1150] .)))

;sentence 9 Span:1151..1313
;Mutations in the p53 gene were found in lung  cancers from lifetime
;nonsmokers (19%) and ex-smokers (67%; odds ratio, 9.08;  95% confidence
;interval, 2.06-39.98).
;[1168..1171]:gene-rna:"p53"
;[1191..1204]:malignancy:"lung  cancers"
(SENT
  (S
    (NP-SBJ-1
      (NP (NNS:[1151..1160] Mutations))
      (PP-LOC (IN:[1161..1163] in)
        (NP (DT:[1164..1167] the) (NN:[1168..1171] p53) (NN:[1172..1176] gene))))
    (VP (VBD:[1177..1181] were)
      (VP (VBN:[1182..1187] found)
        (NP-1 (-NONE-:[1187..1187] *))
        (PP-LOC (IN:[1188..1190] in)
          (NP
            (NP (NN:[1191..1195] lung) (NNS:[1197..1204] cancers))
            (PP (IN:[1205..1209] from)
              (NP
                (NP (JJ:[1210..1218] lifetime) (NNS:[1219..1229] nonsmokers)
                  (PRN (-LRB-:[1230..1231] -LRB-)
                    (NP (CD:[1231..1233] 19) (NN:[1233..1234] %))
                    (-RRB-:[1234..1235] -RRB-)))
                (CC:[1236..1239] and)
                (NP (AFX:[1240..1242] ex) (HYPH:[1242..1243] -)
                    (NNS:[1243..1250] smokers)
                  (PRN (-LRB-:[1251..1252] -LRB-)
                    (FRAG
                      (NP (CD:[1252..1254] 67) (NN:[1254..1255] %))
                      (::[1255..1256] ;)
                      (S
                        (NP-SBJ (NNS:[1257..1261] odds) (NN:[1262..1267] ratio))
                        (,:[1267..1268] ,)
                        (NP-PRD (CD:[1269..1273] 9.08)))
                      (::[1273..1274] ;)
                      (S
                        (NP-SBJ
                          (NML (CD:[1276..1278] 95) (NN:[1278..1279] %))
                          (NN:[1280..1290] confidence)
                           (NN:[1291..1299] interval))
                        (,:[1299..1300] ,)
                        (NP-PRD (CD:[1301..1305] 2.06) (HYPH:[1305..1306] -)
                                (CD:[1306..1311] 39.98))))
                    (-RRB-:[1311..1312] -RRB-)))))))))
    (.:[1312..1313] .)))

;sentence 10 Span:1314..1432
;All deletions were found in tumors from  patients who were either ex-smokers
;or nonsmokers exposed to passive smoking.
;[1318..1327]:variation-type:"deletions"
;[1342..1348]:malignancy:"tumors"
(SENT
  (S
    (NP-SBJ-2 (DT:[1314..1317] All) (NNS:[1318..1327] deletions))
    (VP (VBD:[1328..1332] were)
      (VP (VBN:[1333..1338] found)
        (NP-2 (-NONE-:[1338..1338] *))
        (PP-LOC (IN:[1339..1341] in)
          (NP
            (NP (NNS:[1342..1348] tumors))
            (PP (IN:[1349..1353] from)
              (NP
                (NP (NNS:[1355..1363] patients))
                (SBAR
                  (WHNP-1 (WP:[1364..1367] who))
                  (S
                    (NP-SBJ-1 (-NONE-:[1367..1367] *T*))
                    (VP (VBD:[1368..1372] were)
                      (NP-PRD
                        (NP (CC:[1373..1379] either)
                          (NP (AFX:[1380..1382] ex) (HYPH:[1382..1383] -)
                              (NNS:[1383..1390] smokers))
                          (CC:[1391..1393] or)
                          (NP (NNS:[1394..1404] nonsmokers)))
                        (VP (VBN:[1405..1412] exposed)
                          (NP (-NONE-:[1412..1412] *))
                          (PP (TO:[1413..1415] to)
                            (NP (JJ:[1416..1423] passive)
                                (NN:[1424..1431] smoking))))))))))))))
    (.:[1431..1432] .)))

;sentence 11 Span:1434..1602
;The G:C to A:T transitions (11 of 28; 39%) were the most frequent p53
;mutations  found and clustered in tumors from lifetime nonsmokers without
;passive smoke  exposure.
;[1438..1441]:variation-state-original:"G:C"
;[1445..1448]:variation-state-altered:"A:T"
;[1449..1460]:variation-type:"transitions"
;[1500..1503]:gene-rna:"p53"
;[1504..1513]:variation-event:"mutations"
;[1538..1544]:malignancy:"tumors"
(SENT
  (S
    (NP-SBJ (DT:[1434..1437] The)
      (NML
        (NML (NN:[1438..1439] G) (SYM:[1439..1440] :) (NN:[1440..1441] C))
        (PP (TO:[1442..1444] to)
          (NP (NN:[1445..1446] A) (SYM:[1446..1447] :) (NN:[1447..1448] T))))
      (NNS:[1449..1460] transitions)
      (PRN (-LRB-:[1461..1462] -LRB-)
        (FRAG
          (NP
            (NP (CD:[1462..1464] 11))
            (PP (IN:[1465..1467] of)
              (NP (CD:[1468..1470] 28))))
          (::[1470..1471] ;)
          (NP (CD:[1472..1474] 39) (NN:[1474..1475] %)))
        (-RRB-:[1475..1476] -RRB-)))
    (VP (VBD:[1477..1481] were)
      (NP-PRD
        (NP (DT:[1482..1485] the)
          (ADJP (RBS:[1486..1490] most) (JJ:[1491..1499] frequent))
          (NN:[1500..1503] p53) (NNS:[1504..1513] mutations))
        (VP (VBN:[1515..1520] found) (CC:[1521..1524] and)
            (VBD:[1525..1534] clustered)
          (NP (-NONE-:[1534..1534] *))
          (PP-LOC (IN:[1535..1537] in)
            (NP
              (NP (NNS:[1538..1544] tumors))
              (PP (IN:[1545..1549] from)
                (NP
                  (NP (JJ:[1550..1558] lifetime) (NNS:[1559..1569] nonsmokers))
                  (PP (IN:[1570..1577] without)
                    (NP (JJ:[1578..1585] passive) (NN:[1586..1591] smoke)
                        (NN:[1593..1601] exposure))))))))))
    (.:[1601..1602] .)))

;sentence 12 Span:1603..1744
;The incidence of K-ras codon 12 or 13 mutations was 11% (14 of 115  analyzed)
;with no difference between long-term ex-smokers and nonsmokers.
;[1620..1625]:gene-rna:"K-ras"
;[1626..1634]:variation-location:"codon 12"
;[1626..1631]...[1638..1640]:variation-location:"codon"..."13"
;[1641..1650]:variation-event:"mutations"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[1603..1606] The) (NN:[1607..1616] incidence))
      (PP (IN:[1617..1619] of)
        (NP
          (NP
            (NML-3 (NN:[1620..1625] K-ras))
            (NML
              (NML
                (NML-1 (NN:[1626..1631] codon))
                (CD:[1632..1634] 12))
              (NML-2 (-NONE-:[1634..1634] *P*))))
          (CC:[1635..1637] or)
          (NP
            (NML-3 (-NONE-:[1637..1637] *P*))
            (NML
              (NML
                (NML-1 (-NONE-:[1637..1637] *P*))
                (CD:[1638..1640] 13))
              (NML-2 (NNS:[1641..1650] mutations)))))))
    (VP (VBD:[1651..1654] was)
      (NP-PRD
        (NP (CD:[1655..1657] 11) (NN:[1657..1658] %)
          (PRN (-LRB-:[1659..1660] -LRB-)
            (NP
              (NP (CD:[1660..1662] 14))
              (PP (IN:[1663..1665] of)
                (NP
                  (NP (CD:[1666..1669] 115))
                  (VP (VBN:[1671..1679] analyzed)
                    (NP (-NONE-:[1679..1679] *))))))
            (-RRB-:[1679..1680] -RRB-)))
        (PP (IN:[1681..1685] with)
          (NP
            (NP (DT:[1686..1688] no) (NN:[1689..1699] difference))
            (PP (IN:[1700..1707] between)
              (NP
                (NP
                  (NML (JJ:[1708..1712] long) (HYPH:[1712..1713] -)
                       (NN:[1713..1717] term))
                  (AFX:[1718..1720] ex) (HYPH:[1720..1721] -)
                   (NNS:[1721..1728] smokers))
                (CC:[1729..1732] and)
                (NP (NNS:[1733..1743] nonsmokers))))))))
    (.:[1743..1744] .)))

;sentence 13 Span:1745..1867
;These  and other results indicate that p53 mutations occur more commonly in
;smokers and  ex-smokers than in never-smokers.
;[1784..1787]:gene-rna:"p53"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[1745..1750] These)
        (NML-1 (-NONE-:[1750..1750] *P*)))
      (CC:[1752..1755] and)
      (NP (JJ:[1756..1761] other)
        (NML-1 (NNS:[1762..1769] results))))
    (VP (VBP:[1770..1778] indicate)
      (SBAR (IN:[1779..1783] that)
        (S
          (NP-SBJ (NN:[1784..1787] p53) (NNS:[1788..1797] mutations))
          (VP (VBP:[1798..1803] occur)
            (ADVP
              (ADVP (RBR:[1804..1808] more) (RB:[1809..1817] commonly))
              (PP-LOC (IN:[1818..1820] in)
                (NP
                  (NP (NNS:[1821..1828] smokers))
                  (CC:[1829..1832] and)
                  (NP (AFX:[1834..1836] ex) (HYPH:[1836..1837] -)
                      (NNS:[1837..1844] smokers))))
              (PP (IN:[1845..1849] than)
                (PP-LOC (IN:[1850..1852] in)
                  (NP (RB:[1853..1858] never) (HYPH:[1858..1859] -)
                      (NNS:[1859..1866] smokers)))))))))
    (.:[1866..1867] .)))

;sentence 14 Span:1868..1983
;Such comparisons provide additional evidence  of genetic damage caused by
;tobacco smoke during lung carcinogenesis.
(SENT
  (S
    (NP-SBJ (JJ:[1868..1872] Such) (NNS:[1873..1884] comparisons))
    (VP (VBP:[1885..1892] provide)
      (NP
        (NP (JJ:[1893..1903] additional) (NN:[1904..1912] evidence))
        (PP (IN:[1914..1916] of)
          (NP
            (NP (JJ:[1917..1924] genetic) (NN:[1925..1931] damage))
            (VP (VBN:[1932..1938] caused)
              (NP (-NONE-:[1938..1938] *))
              (PP (IN:[1939..1941] by)
                (NP-LGS (NN:[1942..1949] tobacco) (NN:[1950..1955] smoke)))
              (PP-TMP (IN:[1956..1962] during)
                (NP (NN:[1963..1967] lung) (NN:[1968..1982] carcinogenesis))))))))
    (.:[1982..1983] .)))

;section 15 Span:1987..2032
;PMID: 11389059 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1987..1991] PMID) (::[1991..1992] :) (CD:[1993..2001] 11389059)
        (NN:[2002..2003] -LSB-) (NNP:[2003..2009] PubMed) (::[2010..2011] -)
        (NN:[2012..2019] indexed) (IN:[2020..2023] for)
        (NNP:[2024..2032] MEDLINE-RSB-)))
